Compare GH & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GH | GBCI |
|---|---|---|
| Founded | 2011 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.6B |
| IPO Year | 2018 | N/A |
| Metric | GH | GBCI |
|---|---|---|
| Price | $103.60 | $42.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 5 |
| Target Price | ★ $79.19 | $51.80 |
| AVG Volume (30 Days) | ★ 2.9M | 715.8K |
| Earning Date | 10-29-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.07% |
| EPS Growth | N/A | ★ 26.70 |
| EPS | N/A | ★ 2.05 |
| Revenue | ★ $902,569,000.00 | $900,148,000.00 |
| Revenue This Year | $34.72 | $13.46 |
| Revenue Next Year | $26.46 | $27.84 |
| P/E Ratio | ★ N/A | $20.94 |
| Revenue Growth | ★ 30.38 | 15.35 |
| 52 Week Low | $29.91 | $36.76 |
| 52 Week High | $112.43 | $58.54 |
| Indicator | GH | GBCI |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 51.25 |
| Support Level | $98.23 | $41.93 |
| Resistance Level | $112.43 | $43.38 |
| Average True Range (ATR) | 5.44 | 1.24 |
| MACD | -0.54 | 0.35 |
| Stochastic Oscillator | 64.46 | 78.09 |
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.